| Primary |
| Prophylaxis Of Nausea And Vomiting |
58.0% |
| Nausea |
10.2% |
| Chemotherapy |
8.5% |
| Premedication |
5.4% |
| Breast Cancer |
4.7% |
| Antiemetic Supportive Care |
2.4% |
| Vomiting |
2.4% |
| Neoplasm Malignant |
1.7% |
| Electrolyte Imbalance |
1.4% |
| Prophylaxis |
1.0% |
| Gastric Cancer |
0.7% |
| Non-small Cell Lung Cancer |
0.7% |
| Prophylactic Chemotherapy |
0.7% |
| Colon Cancer |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Head And Neck Cancer |
0.3% |
| Inflammation |
0.3% |
| Lung Disorder |
0.3% |
| Malignant Melanoma |
0.3% |
| Nicotine Dependence |
0.3% |
|
| Throat Tightness |
12.0% |
| Dyspnoea |
9.6% |
| Anaphylactic Shock |
6.4% |
| Hypersensitivity |
6.4% |
| Erythema |
4.8% |
| Feeling Abnormal |
4.8% |
| Flushing |
4.8% |
| Nausea |
4.8% |
| Oxygen Saturation Decreased |
4.8% |
| Pain In Extremity |
4.8% |
| Phlebitis |
4.8% |
| Vomiting |
4.8% |
| Feeling Hot |
4.0% |
| Unresponsive To Stimuli |
4.0% |
| Anaphylactic Reaction |
3.2% |
| Chest Pain |
3.2% |
| Convulsion |
3.2% |
| Infusion Site Reaction |
3.2% |
| Loss Of Consciousness |
3.2% |
| Urticaria |
3.2% |
|
| Secondary |
| Prophylaxis Of Nausea And Vomiting |
37.9% |
| Breast Cancer |
25.0% |
| Premedication |
12.5% |
| Nausea |
5.8% |
| Neoplasm Malignant |
5.4% |
| Antiemetic Supportive Care |
4.5% |
| Non-small Cell Lung Cancer |
2.7% |
| Prophylaxis |
2.7% |
| Vomiting |
2.7% |
| Prophylactic Chemotherapy |
0.9% |
|
| Interstitial Lung Disease |
12.8% |
| Flushing |
10.3% |
| Skin Reaction |
10.3% |
| Throat Tightness |
7.7% |
| Feeling Hot |
6.4% |
| Infusion Site Phlebitis |
6.4% |
| Vascular Access Complication |
6.4% |
| Erythema |
5.1% |
| Pain In Extremity |
3.8% |
| Tremor |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Cardiac Arrest |
2.6% |
| Dyspnoea |
2.6% |
| Hyperhidrosis |
2.6% |
| Hypertension |
2.6% |
| Infusion Site Pain |
2.6% |
| Infusion Site Urticaria |
2.6% |
| Injection Site Vasculitis |
2.6% |
| Pruritus |
2.6% |
| Syncope |
2.6% |
|
| Concomitant |
| Breast Cancer |
60.0% |
| Graft Versus Host Disease |
10.0% |
| Infection Prophylaxis |
10.0% |
| Stem Cell Transplant |
10.0% |
| Transplant Rejection |
10.0% |
|
| Cardiovascular Disorder |
66.7% |
| Vomiting |
33.3% |
|
